Trelegy Ellipta (fluticasone/umeclidinium/vilanterol) is a brand-name inhaler that’s prescribed for certain breathing problems in adults. The cost of the drug with and without insurance can depend on several factors.
Trelegy Ellipta contains medications from three classes of drugs:
- an inhaled corticosteroid (fluticasone)
- an anticholinergic drug (umeclidinium)
- a long-acting beta agonist (vilanterol)
Trelegy Ellipta is not available in a generic version.
Read on to learn about Trelegy Ellipta and cost, as well as how to save money on prescriptions. If you’d like other information about Trelegy Ellipta, refer to this article.
As with all medications, the cost of Trelegy Ellipta can vary. Factors that may affect the price you’ll pay include:
- your treatment plan
- your insurance coverage
- the pharmacy you use
- whether Trelegy Ellipta has a savings program (see the “Financial and insurance assistance” section below)
To find out what the cost of Trelegy Ellipta will be for you, talk with your doctor, pharmacist, or insurance provider.
Note: If you have insurance, your insurance company may require prior authorization before it covers Trelegy Ellipta. This means the company and your doctor will discuss Trelegy Ellipta in regard to your treatment. The insurance company will then determine whether the medication is covered. If a drug requires prior authorization but you start treatment without the prior approval, you could pay the full cost of the medication. You can ask your insurance company whether Trelegy Ellipta requires prior authorization.
Here are answers to some frequently asked questions about drug cost and Trelegy Ellipta.
Is Trelegy Ellipta covered by Medicare?
To find out whether your Medicare plan will cover Trelegy Ellipta, contact your plan provider.
How does the cost of Trelegy Ellipta compare with the cost of Breo Ellipta?
The cost of Trelegy Ellipta compared with the cost of Breo Ellipta depends on several factors. These include whether you have insurance, your specific insurance plan, and whether the drug has a savings program.
Trilogy Ellipta and Breo Ellipta are both prescribed to treat certain breathing problems in adults, such as chronic obstructive pulmonary disease and asthma.
To find out the cost of Trelegy Ellipta compared with Breo Ellipta, talk with your doctor, pharmacist, or insurance provider. You can also refer to the “Financial and insurance assistance” section below for information about Trelegy savings programs.
Trelegy Ellipta is only available as a brand-name drug. It doesn’t come in a generic version. A generic drug is an exact copy of the active drug in a brand-name medication.
Generics tend to cost less than brand-name drugs.
WHY ARE COSTS DIFFERENT FOR BRAND-NAME DRUGS VS. GENERIC DRUGS?
Brand-name drugs can be expensive because of the research needed to test their safety and effectiveness. The manufacturer of a brand-name drug can sell it for up to 20 years. When the brand-name drug’s patent expires, multiple manufacturers can create generic versions. This marketplace competition may lead to lower costs for generics. Also, because generics contain the same active ingredients as brand-name drugs, they don’t require the same costly testing.
If you take Trelegy Ellipta long term, you may be able to lower its cost in the following ways.
Getting a 3-month supply
You may be able to get a 90-day supply of Trelegy Ellipta. If approved by your insurance company, getting a 90-day supply of the drug could reduce your number of trips to the pharmacy and help lower the cost. If you’re interested in this option, check with your doctor, pharmacist, or insurance provider.
If you don’t have health insurance, talk with your doctor or pharmacist. They may be able to suggest online pharmacy options that could work for you.
If you need financial support to pay for Trelegy Ellipta, or if you need help understanding your insurance coverage, help is available. For example:
- A program called Trelegy Savings and Coupon is available for Trelegy Ellipta. For more information and to find out if you’re eligible for support, call 866-475-3678 or visit the program website.
- Some websites provide details about drug assistance programs, ways to make the most of your insurance coverage, and links to savings cards and other services. Two such websites are:
To learn more about saving money on prescriptions with or without insurance, check out this article.
Now that you’ve learned about cost and Trelegy Ellipta, you may still have some questions. Talk with your doctor or pharmacist, who can provide personalized guidance about cost issues related to Trelegy Ellipta. But if you have health insurance, you’ll need to talk with your insurance provider to learn the actual cost you would pay for Trelegy Ellipta.
Here are some other resources you may find helpful:
- Medicare drug coverage. To learn about Medicare coverage for drugs, see these articles about Medicare prescription drug plans, drug coupons and Medicare, and the Medicare drug list.
- More details. For details about other aspects of Trelegy Ellipta, refer to this article.
- Dosage. Learn about Trelegy Ellipta and dosage by viewing this article.
- Side effects. For details about Trelegy Ellipta’s side effects, see this article. You can also look at the Trelegy Ellipta prescribing information.
- Information about your condition. For more information about chronic obstructive pulmonary disease (COPD), see our COPD hub. To learn more about asthma, you can refer to our list of asthma articles.
Disclaimer: Medical News Today has made every effort to make certain that all information is factually correct, comprehensive, and up to date. However, this article should not be used as a substitute for the knowledge and expertise of a licensed healthcare professional. You should always consult your doctor or another healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses.